Publication | Closed Access

NRPa-308, a new neuropilin-1 antagonist, exerts in vitro anti-angiogenic and anti-proliferative effects and in vivo anti-cancer effects in a mouse xenograft model

Mouse Xenograft ModelAngiogenesisMedicineEndothelial DysfunctionVivo Anti-cancer EffectsVascular BiologyPharmacotherapyAnti-cancer AgentRadiation OncologyPharmacologyGliomaNew Neuropilin-1 AntagonistTumor MicroenvironmentCancer Research